Molnupiravir pills (Photo: VNA)Hanoi (VNA) – Three pharmaceutical companies in Vietnam are planning to or are producing Molnupiravir pills to treat with ,
according to the Ministry of Health.
Of the three, the drug manufactured by Stellapharm Vietnam
has been approved for clinical trial. Because Molnupiravir has yet been granted
with a circulation registration number in Vietnam, the Ministry of Health is
considering asking the Government for approval of using the drug in
emergency cases. If approved by the Government, it is expected that three registration
numbers will be issued for three types of Molnupiravir drugs manufactured by domestic
pharmaceutical companies.
Regarding the effectiveness of Molnupiravir on patients in Vietnam,
the Department of Science, Technology and Training under the Ministry of Health
said that from the end of August, the ministry has piloted using
for non-hospitalised patients. Ho Chi Minh City was the first locality to implement
this pilot programme. At present, it has been arried out in 34 provinces and
cities.
The ministry has provided 110,000 doses, including 50,000
doses of Molnupiravir 400 mg Stella VN, and 60,000 doses of Molnupiravir 200 mg
Optimus produced by India to localities.
The use of the drug in 22 provinces and cities show
that Molnupiravir is safe and well-accepted, and has obvious effectiveness in
reducing viral load, virus spread and the number of severe cases, and
shortening treatment time, with no fatalities recorded.
Molnupiravir is developed by the US-based pharmaceutical
companies Ridgeback Biotherapeutics and Merck & Co., Inc./.
Source: VietnamPlus
